期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 16, 期 2, 页码 79-80出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41571-018-0138-4
关键词
-
类别
In 2018, advances in the treatment of non-small-cell lung cancer (NSCLC) have been observed both in trials of immunotherapies and targeted agents, leading to dramatically improved options for patients with metastatic and stage III NSCLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据